Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.59 |
| ▸ | CXCR5 | P32302 | 2/20 | 0.59 |
| ▸ | APLNR | P35414 | 2/20 | 0.59 |
| ▸ | CCR6 | P51684 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | GFER | P55789 | 1/20 | 0.59 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.47 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.47 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.47 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1492528 | 0.81 | KMT2A (0.64) | AGTR1KMT2AHSP90AA1CXCR5APLNR | |
| SCHEMBL30184492 | 0.81 | KMT2A (0.64) | AGTR1KMT2AHSP90AA1CXCR5APLNR | |
| SCHEMBL1134371 | 0.81 | AGTR1 (0.61) | AGTR1KMT2AHSP90AA1CXCR5APLNR | |
| Hydrochloric Acid SCHEMBL6196645 | 0.80 | AGTR1 (0.59) | AGTR1KMT2AHSP90AA1CXCR5APLNR | |
| SCHEMBL31527799 | 0.80 | AGTR1 (0.64) | AGTR1KMT2AHSP90AA1CXCR5APLNR | |
| SCHEMBL13713054 | 0.78 | AGTR1 (0.54) | AGTR1KMT2AHSP90AA1CXCR5APLNR | |
| SCHEMBL4976522 | 0.77 | KMT2A (0.59) | AGTR1KMT2AHSP90AA1CXCR5APLNR | |
| SCHEMBL3156019 | 0.76 | MAPT (0.52) | AGTR1KMT2AHSP90AA1CXCR5APLNR | |
| SCHEMBL11400975 | 0.75 | AGTR1 (0.75) | AGTR1KMT2AHSP90AA1CXCR5APLNR | |
| SCHEMBL4973717 | 0.75 | RAB9A (0.56) | AGTR1KMT2AHSP90AA1CXCR5APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350233-A | Preparation method of aryl sulfonic acid compound | 上海麦克林生化科技股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-109456257-B | Preparation method of high-yield 2-chloro-5-nitropyridine | 新发药业有限公司 | 2020-04-28 | — | — | CN | disclosed |
| CN-109456257-A | A kind of preparation method of high yield 2- chloro-5-nitropyridine | 新发药业有限公司 | 2019-03-12 | — | — | CN | disclosed |
| CN-1749252-B | Compounds useful to treat retroviral infections | PHARMACIA & UPJOHN CO LLC (US) | 2011-06-08 | — | — | CN | disclosed |
| US-20100256092-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2010-10-07 | — | — | US | disclosed |
| WO-2009140309-A2 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2009-11-19 | — | — | WO | disclosed |
| CN-1329378-C | Compounds for the treatment of retroviral infections | PHARMACIA & UPJOHN CO LLC (US) | 2007-08-01 | — | — | CN | disclosed |
| CN-1749252-A | Compounds useful to treat retroviral infections | PHARMACIA & UPJOHN CO LLC (US) | 2006-03-22 | — | — | CN | disclosed |
| CN-1539825-A | Compounds for the treatment of retroviral infections | �������Ŷ���Լ��������˾ | 2004-10-27 | — | — | CN | disclosed |
| CN-1154642-C | Compounds for the treatment of retroviral infections | �������Ŷ���Լ��������˾ | 2004-06-23 | — | — | CN | disclosed |
| CN-1150424-A | Compounds for the treatment of retroviral infections | UPJOHN CO (US) | 1997-05-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256092-A1 | BORON-CONTAINING SMALL MOLECULES | BCL6B, BCL6, BTD | AGTR1 3696/4885KMT2A 1841/4885HSP90AA1 745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.